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There is a limited evaluation of an independent linguistic battery for early diagnosis of Mild
Cognitive Impairment due to Alzheimer’s disease (MCI-AD). We hypothesized that an independent linguistic battery comprising of only the language components or subtests of popular test batteries could give a better clinical diagnosis for MCI-AD compared to using an
exhaustive battery of tests. As such, we combined multiple clinical datasets and performed
Exploratory Factor Analysis (EFA) to extract the underlying linguistic constructs from a combination of the Consortium to Establish a Registry for Alzheimer’s disease (CERAD),
Wechsler Memory Scale (WMS) Logical Memory (LM) I and II, and the Boston Naming
Test. Furthermore, we trained a machine-learning algorithm that validates the clinical relevance of the independent linguistic battery for differentiating between patients with MCI-AD
and cognitive healthy control individuals. Our EFA identified ten linguistic variables with distinct underlying linguistic constructs that show Cronbach’s alpha of 0.74 on the MCI-AD
group and 0.87 on the healthy control group. Our machine learning evaluation showed a
robust AUC of 0.97 when controlled for age, sex, race, and education, and a clinically reliable AUC of 0.88 without controlling for age, sex, race, and education. Overall, the linguistic
battery showed a better diagnostic result compared to the Mini-Mental State Examination
(MMSE), Clinical Dementia Rating Scale (CDR), and a combination of MMSE and CDR.

Introduction
Mild Cognitive Impairment due to Alzheimer’s disease (MCI-AD) is a precursor to Alzheimer’s disease (AD) [1–3]. It is characterized by a cognitive decline that is usually associated
with aging or AD [4]. Some of the profound characteristics of MCI-AD are the gradual degrading of cognitive speech functions, which is often affected long before the diagnosis of MCI-AD
[5]. Research has shown that neurodegenerative disease such MCI-AD deteriorates nerve cells
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that control cognitive speech and language processes, and therefore affect the ability of an individual to make effective verbal utterances [6, 7].
The need for early detection of MCI-AD using linguistic biomarkers has been growing in
recent years [6–12]. However, it is still prevalent to diagnose MCI-AD using a combination of
neuropsychological batteries and a doctor’s longitudinal observation of the individual [13]. A
more popular option is to use the Mini-Mental State Examination (MMSE) instrument which
looks for gross cognitive deficits that may not be sensitive enough to capture low-level cognitive deficits that often characterize MCI-AD [14, 15]. It is also common to combine the MMSE
with another test battery [13]. The Montreal Cognitive Assessment (MoCA)[16], Clinical
Dementia Rating Scale (CDR) [17], Boston Naming Test (BNT) [18], and the Consortium to
Establish a Registry for Alzheimer’s disease (CERAD) battery [19], are often combined to diagnose MCI-AD. Administering these neuropsychological batteries can be lengthy and complicated [16]. At the same time, each test battery would typically assess multiple cognitive deficits.
The clinician would then need to make a challenging determination of an ideal diagnosis by
considering all the possible cognitive deficits linked to different variants of a neuropsychological disorder [20].
Some independent linguistic subtests are available as part of the existing test battery such as
the CERAD battery [21]. Many of the CERAD linguistic subtests have been assessed or validated independently or as part of a combined battery [22]. What is often less studied, however,
is the combination of multiple linguistic subtests to create an independent linguistic battery
for early diagnosis of MCI-AD using language alone. An independent linguistic battery could
reduce the test burden on patients over a large population while at the same time increases the
effectiveness of the diagnosis even with less test time.
For example, the efficacy of the Wechsler Logical Memory (WLM) I and II, which are two
of the five different subtests of the Wechsler Memory Scale (WMS) [23], have been reported
by some researchers to independently screen MCI-AD patients through a narrative task [6, 15,
24]. The WLM involves two narrative tasks, where the participants listen to a tale and then
retell the tale both immediately after listening to the story and after a delayed period of about
30 minutes. The immediate retell is known as the WLM I, and the delayed retell is known as
WLM II. A famous tale that is often used for the clinical diagnosis of MCI-AD is the Anna
Thompson story [15]. Each narrative of the participant is scored based on the number of story
elements in the narrative. The WLM I and II give a single summary score for retelling the narrative, immediate memory, and delayed memory [11, 15, 21, 24].
Similarly, the CERAD Word List Memory subtest, which is a part of the CERAD neuropsychological assessment battery, has proven to be useful in the neuropsychological assessment of
cognitive deficits in patients with MCI-AD [21, 25]. Like the WMS, the CERAD battery combines multiple subtests which require individual interpretations. The CERAD Word List
Memory subtest of the larger CERAD battery is presented to the participants in three trials
[25]. At every 2 seconds, participants are required to read each word aloud. At the end of the
reading task, participants would recall as many words as possible from the list in a single trial.
Each trial has a maximum of 10 correct answers summing up to 30 correct answers in the
three trials. Different scores can be calculated from the trials, including delayed recall and
recognition, among other varying predefined scores [25]. In the same manner, the BNT is
commonly used to access language-related cognitive deficits in MCI-AD and other neuropsychological disorders using confrontational word retrieval technique [26]. Both the 30-item
BNT and 60-item BNT are commonly used to assess naming difficulties among patients with
cognitive deficits. Patients are asked to say the names of specific images with a period of 20 seconds between multiple trials.
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While the above test battery has been proven clinically useful [16, 20, 27, 28], we hypothesized that an independent linguistic battery comprising of only the language components or
subtests of these popular test batteries could give better clinical diagnosis for the MCI-AD
compared to using an exhaustive battery of tests. As such, we combined multiple clinical datasets and performed Exploratory Factor Analysis (EFA) to extract relevant language-based subtests from a combination of the CERAD word list, WLM language subtests, and the BNT
subtests. Furthermore, while the EFA identified variables that show the underlying structure of
the data, we trained a machine-learning algorithm that validates the clinical relevance of the
independent linguistic battery for diagnosing MCI-AD using the loaded variables from the
EFA.

Methods
Datasets
We used two datasets in this study. We obtained the first dataset from the Layton Aging and
Alzheimer’s Disease Center and the Oregon Center for Aging and Technology Research
Repository (http://www.ohsu.edu/xd/research/centers-institutes/orcatech/index.cfm), which
is part of an existing study on MCI and AD at the Oregon Health and Science University
(OHSU). The second dataset is based on the National Alzheimer’s Coordinating Center
(NACC) Uniform Data sets version 3.0 (UDS 3.0)(https://www.alz.washington.edu/WEB/
data_descript.html).
The OHSU study used a battery of tests like the CERAD battery (i.e., CDR, MMSE, CERAD
Word List, WLM I & II, WAIS-R, and the BNT) to follow participants over a longitudinal
period with at least a 6-month interval. The dataset consists of 34 healthy control individuals
without any cognitive impairments and a matching 34 individuals with MCI. There were no
significant age differences between the control and the MCI participants in that study. The
individuals with MCI were diagnosed based on individual scores from the used battery of tests,
including the CDR, Collateral CDR, and MMSE scores. A CDR score of 0 corresponds to the
absence of MCI, while a CDR score of 0.5 or more and an MMSE score below 24 indicate the
likelihood of MCI.
We extracted participants’ scores from the WLM subtests, CERAD Word List subtest, and
the BNT subtests from the dataset. We extracted ten language-based items scores (wordlist
used, wordlist cannot read, wordlist trial 1, wordlist trial 2, wordlist trial 3, wordlist acquisition,
wordlist intrusions, wordlist delayed recall, wordlist delayed intrusions, wordlist list recognition)
from the CERAD word list. Also, we extracted both the WLM I and WLM II scores from the
dataset. More importantly, as at the time of conducting the OHSU study, the WMS-III battery
was the existing version on which the WLM I and II were based.
The NACC UDS is based on data from 34 Alzheimer’s disease Centers founded by the
National Institutes of Health. The dataset consists of multiple subject visits over ten years
beginning from 2005. For this study, we extracted data from the third visit only since it contains unique participants with a sufficiently large number balanced across the MCI-AD diagnosed patients and the matching healthy control individuals. There were 197 MCI-AD and
270 cognitive healthy unique subjects in the third visit. Upon removing observations with
non-relevant responses such as unknown, there were 178 MCI-AD and 270 cognitive healthy
unique subjects remaining in the dataset.
For this study, we combined both the OHSU dataset and the NACC UDS dataset into a single dataset. Both datasets share the same set of variables as required for the linguistic battery
apart from the ten CERAD wordlist items which are only present in the OHSU dataset. As
such, we used multiple imputation techniques to construct a complete dataset with all the
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relevant variables [29]. Multiple imputation techniques have become popular in clinical
research [29, 30]. The technique allows for filling in missing data from the observed data.
More importantly, multiple imputations introduced uncertainties about the missing data
through multiple iterations (bootstrapping) of generating different datasets based on the predictive distribution of the observed data [31]. In the end, the generated datasets are harmonically combined to obtain a single and plausible dataset [30]. We performed ten iterations of
multiple imputations with a random seed of 54321 to impute the ten CERAD word list variables for the NACC UDS data based on the OHSU data. The multiple imputation process generated a total of 4,480 observations, which is the number of the original observations in ten
places. Note that because the imputed data were either missing at random (MAR) or missing
completely at random (MCAR) as a result of the combination of multiple datasets [30], there is
substantial evidence in the literature that the multiple imputation techniques effectively reduce
bias even with a large proportion of missing data [32, 33].

Analysis
We divided the OHSU dataset into MCI-AD and Control groups. We performed Exploratory
Factor Analysis (EFA) to extract latent linguistic constructs from the combined imputed dataset [34]. The EFA was performed on each independent group (i.e., MCI-AD and healthy control) to show the underlying constructs in each group and determine whether the constructs
could adequately characterize the presence or absence of MCI-AD. Furthermore, the EFA
shows the validity of the underlying constructs to the diagnosis of MCI-AD or otherwise. We
based the validity evidence on the internal structure matrix of the EFA and a reliability measure of the internal consistency between the underlying constructs and the linguistic variables.
The Principal Axis Factoring (PAF) was used as the extraction method for the EFA since all
the variables do not have a normal distribution [35]. We specified the varimax orthogonal
rotation to produce an uncorrelated factor in order to identify all possible underlying linguistic
constructs [35]. For both the MCI-AD and healthy control groups, three factors were suggested to be appropriate by a scree test. A 0.4 cut-off point was set to identify variables that sufficiently load on each factor [29]. We excluded variables that loaded on multiple factors in the
interpretation of the results.
A bivariate correlation analysis was performed to show correlations between the underlying
linguistic constructs and all the variables using the Spearman correlation coefficient [36].
The purpose was to show the degree of relationship between the linguistic variables and the
underlying constructs of MCI-AD and control groups. Furthermore, to ascertain internal
consistency between the variables, we measured the reliability of the linguistic battery for differentiating between patients with MCI-AD and healthy controls using Cronbach’s alpha
(α) coefficient [37].
Finally, for clinically diagnosed patients with MCI-AD, variables which loaded on the linguistic constructs from the EFA were used to train Support Vector Machines (SVM) algorithm
[38], which is one of the famous and most robust machine learning algorithms [39]. We measured the performance of the machine learning algorithm using the Area Under the receiver
operating characteristics (ROC) Curve (AUC) [40, 41]. The AUC is famous for evaluating the
performance of clinical diagnostic and predictive models [42]. The AUC makes a tradeoff
between the sensitivity (true positive rate) and the specificity (true negative rate) [40]. The percentage of positive and accurately classified observations is known as sensitivity. On the other
hand, the specificity computes the percentage of negative observations which were accurately
classified as negative. When the sensitivity of a classifier is 0.0, and the specificity is 1.0, then
the confidence score of the diagnostic test is below the set threshold [11]. Conversely, when
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the specificity is 0.0, and sensitivity is 1.0, it means the confidence score of the diagnostic test is
above the set threshold. A random diagnostic test has an AUC of 0.5 with a diagonal line connecting the origin (0, 0) to the final point (1, 1). An AUC of 1.0 is a perfect diagnostic test that
ranks all positive observations above all negative observations [40]. While different clinical
diagnostic scenarios make different tradeoff with the AUC, the recommended AUC for clinical
purposes is 75 and above [15, 43].
Statistical analyses (EFA and correlations) were performed using the Statistical Analysis
Software (SAS) version 9.4. The machine learning experiments and evaluation were performed
in RStudio version 1.1.463 using the e1071 package for the SVM experiments [38], pROC
package for the AUC evaluations [42], and the gplots package for the heatmaps [45].

Results & discussion
Summary statistics
Table 1 shows the summary statistics of the combined dataset before the multiple imputations were performed. The summary excludes the CERAD word list variables as they were
not part of the NACC UDS data. The number of observations in each group excludes observations with at least one missing value. Compared to the male patients, there was a higher
number of female patients in both the MCI-AD (58.8%) and the control groups (58.2%).
About 91% of the MCI-AD were whites, while around 93% of the healthy controls were
whites. Surprisingly, the MCI-AD group had, on average, more years of education (16.21
±9.05) compared to the healthy control group (15.50±6.07), however, the difference is not
statistically significant. Also, there was no statistically significant difference between the
mean age of the MCI-AD (85.39±7.56) and the control (84.18±6.91) group. CDR, LMI, and
LMII had a statistically significant difference between the MCI-AD and control groups. On
average, the CDR was higher in the MCI-AD (0.12±0.22) compared to the control group
(0.05±0.17). Compared to the MCI-AD group, the control group had higher LMI and LMII
values on average. There was no statistically significant difference between the MCI-AD and
control groups for the MMSE and Boston variables. Note that the BNT variable is referred to
as Boston in both datasets.
Table 2 shows the summary statistics of the imputed datasets for the MCI-AD and control
groups from the ten iterations of multiple imputations. Among the demographic variables,
there was no statistical significance between male and female patients. Most of the CERAD
word list variables were statistically significant, except wordlistcantread, wordlistintrusions,
and wordlistrecognition.
Table 1. Summary statistics for the combined dataset before multiple imputations. The number of observations is shown for each category of sex and race. Mean (standard deviation) is shown for all other variables. n excludes observations with missing values.
p-value

Variable

MCI-AD (n = 187)

Control (n = 261)

SEX (Male/Female)

77/110

109/152

0.9015

RACE(White/Black/Asian)

170/16/0

243/17/1

0.3143

EDUCATION (Years)

16.21(9.05)

15.50(6.07)

0.3514

AGE (Years)

85.39(7.56)

84.18(6.91)

CDR

0.12(0.22)

0.05(0.17)

MMSE

27.18(2.05)

27.56(2.85)

0.1000

LM I

10.64(4.39)

11.51(4.76)

0.0500

LM II

8.88(4.82)

9.89(5.27)

0.0400

BOSTON

25.35(3.43)

25.85(3.74)

0.0900

0.0795
<0.0000

https://doi.org/10.1371/journal.pone.0229460.t001
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Table 2. Summary statistics of the imputed datasets for the MCI-AD and control groups from the ten iterations of multiple imputations. Mean (standard deviation)
is shown for all other variables.
p-value

Variable

MCI-AD (n = 1870)

Control (n = 2610)

SEX

1.59 (0.49)

1.58(0.49)

RACE

1.61(7.15)

1.08(0.35)

0.0014

EDUCATION (Years)

16.21(9.03)

15.50(6.06)

0.0031

0.6948

AGE (Years)

85.39(7.54)

84.18(6.90)

<0.0001

CDR

0.12(0.22)

0.05(0.17)

<0.0001

MMSE

27.18(2.05)

27.56(2.85)

<0.0001

LM I

10.68(4.38)

11.51(4.75)

<0.0001

LM II

8.93(4.81)

9.89(5.26)

<0.0001

BOSTON

25.38(3.41)

25.94(3.73)

<0.0001

WORDLISTUSED

1.43(0.74)

1.48 (0.59)

0.0169

WORDLISTCANTREAD

0.12(2.00)

0.05(1.58)

0.2012

WORDLISTTRIALI

4.51(2.73)

4.83(1.99)

<0.0001

WORDLISTTRIALII

6.16(2.40)

6.51(1.89)

<0.0001

WORDLISTTRIALIII

6.93(2.68)

7.27(1.88)

<0.0001

WORDLISTACQUISITION

17.67(6.12)

18.67(4.81)

<0.0001

WORDLISTINTRUSIONS

0.61(2.85)

0.64(1.42)

0.6174

WORDLISTDELAYEDRECALL

5.37(3.35)

5.89(2.53)

<0.0001

WORDLISTDELAYEDINTRUSIONS

0.36(1.04)

0.21(0.80)

<0.0001

WORDLISTRECOGNITION

19.16(4.80)

19.08(1.64)

0.4592

https://doi.org/10.1371/journal.pone.0229460.t002

Underlying linguistic constructs with exploratory factor analysis
Table 3 shows the underlying linguistic constructs for patients with MCI-AD. On that group,
the logical memory subtests and the CERAD wordlist subtests loaded on the three factors. We
observed that the MCI-AD group could be characterized as having linguistic deficits that can
be measured by different linguistic constructs. We identified three different linguistic themes
based on the variables that uniquely loaded on each of the factors. Most of the loaded variables
have communalities above 70%, which shows a substantial amount of each variable’s variance
that is explainable by the factors [46].
Factor 1 represents a linguistic translation construct (wordlist recognition, wordlist recall,
and wordlist intrusion) that shows the impaired ability of the patients to perform recognition
and recall processes with a certain level of intrusion or disturbances during that process. Since
the combined dataset consists of a predominantly white population, we can only infer that the
linguistic translation construct might be specific to patients with MCI-AD who are whites.
Factor 2 shows the evidence of linguistic retention construct (wordlist learning trials II, III,
wordlist acquisition), which shows the inability of patients with MCI-AD to learn and retain
certain linguistic components successfully. Finally, Factor 3 implies the evidence of linguistic
transient construct as observed in the immediate and delayed components of the logical memory (LMI and LMII) subtests with the negatively loaded wordlist delayed intrusions.
We believe these three linguistic themes (linguistic translation, emphlinguistic retention,
and linguistic transient) speak to the non-trivial nature of diagnosing the MCI-AD group. At
the same time, we believe our analysis uncovers the fact that no single underlying construct
can characterize the complicated nature of MCI-AD [2, 13]. As such, these multiple linguistic
constructs could be used in a linguistic battery that captures essential linguistic biomarkers
for identifying patterns of impaired speech that is specific to patients with MCI-AD [6, 8, 11,
12, 15].
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Table 3. EFA structure matrix for the MCI-AD group. Uniquely loaded variables (>0.40) are marked with asterisks. Important r and communality (Comm.) values are
boldfaced.
Variable

r

Factor1

Factor2

Factor3

Comm.

SEX

0.17

14

6

7

0.03

RACE

0.10

85�

-33

-22

0.88

-0.27

-39

-23

-19

0.24

0.24

-15

-16

25

0.11

-0.41

-9

-25

-5

0.08

MMSE

0.30

0

21

36

0.17

LM I

0.92

4

8

89�

0.81

LM II

0.93

5

7

91�

0.83

EDUCATION (Years)
AGE (Years)
CDR

BOSTON

0.30

0

23

22

0.10

WORDLISTUSED

0.26

-2

2

22

0.05
0.22

WORDLISTCANTREAD

-0.27

-39

26

-2

WORDLISTTRIALI

0.71

73

51

6

0.80

WORDLISTTRIALII

0.82

-23

87�

12

0.82

WORDLISTTRIALIII

0.79

0

87�

1

0.76

WORDLISTACQUISITION

0.95

25

95�

8

0.96

-0.52

-85�

-6

6

0.72

0.74

74�

35

11

0.68

-0.33

-15

-3

-43�

0.20

0.55

92�

-11

-10

0.87

WORDLISTINTRUSIONS
WORDLISTDELAYEDRECALL
WORDLISTDELAYEDINTRUSIONS
WORDLISTRECOGNITION
https://doi.org/10.1371/journal.pone.0229460.t003

Table 4 shows the underlying linguistic construct for the healthy control group. Unlike the
MCI-AD group, the control group loaded differently, albeit with three different underlying
constructs as observed in the MCI-AD group. Also, like the MCI-AD group, most of the
loaded variables showed communalities above 70%, which shows a substantial amount of each
variable’s variance that is explainable by the factors [46]. Factor 1 showed combined evidence
of linguistic translation and linguistic retention constructs. This forms the translate-retention
construct (wordlist delayed recall, wordlist learning trials II, III, wordlist acquisition). The
translate-retention construct characterizes the difficulty of differentiating patients with
MCI-AD from healthy control individuals since many cognitive healthy individuals have been
shown to share overlapping biomarkers with patients who have MCI-AD [8]. We believe the
overlap between MCI-AD and healthy control emphasizes the non-trivial nature of diagnosing
MCI-AD at the early stages. Factor 2 shows the evidence of linguistic competence (MMSE,
LMI, LMII, Boston, and wordlistused) construct as most healthy controls tend to do very well
with the MMSE, logical memory subtests, the Boston naming test, and the number of words
used. The CDR, on the other hand, is famously sensitive to AD of Dementia-type and even less
sensitive to MCI-AD, which could be a reason why it did not load on the MCI-AD. Unlike the
control group, the MCI-AD group did not load on the MMSE, Boston, and wordlistused variables. Finally, Factor 3 shows a certain level of linguistic intrusion construct (wordlist intrusions and wordlist delayed intrusions). It is expected that some of the healthy controls would
load on the linguistic intrusion since both MCI-AD and the control groups are likely to have
similar responses to linguistic disturbances [2, 13].

Correlation between variables and the underlying linguistic constructs
As shown in Tables 3 and 4, all the loaded variables showed moderate to very strong Spearman
correlation coefficients with the identified factors. This shows that the variables are effective in
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Table 4. EFA structure matrix for the control group. Uniquely loaded variables (>0.40) are marked with asterisks. Important r and communality (Comm.) values are
boldfaced.
Variable

r

Factor1

Factor2

Factor3

Comm.

SEX

-0.18

3

-9

-16

0.04

RACE

-0.26

-12

-22

-12

0.08

0.43

-1

45

75

0.76

AGE (Years)

-0.08

-25

2

-9

0.07

CDR

-0.36

-37

-39

11

0.30

MMSE

0.56

32

66�

-22

0.59

LM I

0.83

13

82�

-7

0.69

LM II

0.88

11

84�

-9

0.72

�

EDUCATION (Years)

BOSTON

0.51

37

54

-7

0.44

WORDLISTUSED

0.53

3

59�

0

0.34

-0.11

2

-12

-3

0.01

WORDLISTTRIALI

0.73

72

16

-42

0.73

WORDLISTTRIALII

0.83

84�

23

4

0.77

WORDLISTTRIALIII

0.79

81�

-1

-17

0.69

WORDLISTACQUISITION

0.94

94�

15

-23

0.96

WORDLISTINTRUSIONS

0.50

-19

-23

51�

0.35

WORDLISTDELAYEDRECALL

0.63

�

67

29

-36

0.66

WORDLISTDELAYEDINTRUSIONS

0.76

6

-13

82�

0.70

-0.59

43

21

-64

0.64

WORDLISTCANTREAD

WORDLISTRECOGNITION
https://doi.org/10.1371/journal.pone.0229460.t004

characterizing either the MCI-AD group or the healthy control group. More importantly, we
observed many variables with very strong positive correlations in the MCI-AD group compared to the control group. For example, the LMI and LMII variables in the MCI-AD group
have Spearman correlation coefficients of 0.92 and 0.93, respectively, compared to 0.83 and
0.88 in the healthy control group. We believe these results indicate the difference in the linguistic deficits between the MCI-AD group and the control group. Other loaded variables showed
similar correlation coefficients in both the MCI-AD and control groups.
Also, the between factor correlations showed the difference between the underlying linguistic constructs since we specified the varimax orthogonal rotation to produce an uncorrelated
factor. On the MCI-AD group, Factor 1 had a 51% (p<0.0001) positive correlation with Factor
2 and a 38% (p<0.0001) positive correlation with Factor 3. Factor 2 had a non-significant and
marginal -0.004 (p = 0.8501) correlation with Factor 3. On the healthy control group, however,
Factor 1 had a non-significant 2% (p = 0.3420) negative correlation with Factor 2 and a 4%
(p = 0.0405) positive correlation with Factor 3. Finally, Factor 2 had a 21% (p<0.0001) negative
correlation with Factor 3. Again, we believe the very weak to moderate correlations which
were observed between the extracted factors in the MCI-AD group shows the difficulty in
effectively diagnosing MCI-AD because of its complicated pattern of biomarkers [2, 13]. The
control group, however, demonstrated a clear pattern of uncorrelated underlying linguistic
patterns.
A standardized Cronbach’s alpha of 0.74 was achieved with ten variables from the MCI-AD
group (LMI, LMII, Boston wordlistused, wordlisttrialI, wordlisttrialII, wordlisttrialIII, wordlistacquisition, wordlistdelayedrecall, and wordlistrecorgnition). On the control group, we realized
a standardized Cronbach’s alpha of 0.87 for the same set of variables. We believe that a Cronbach’s alpha of 0.74 on the MCI-AD group showed moderate reliability for this exploratory
phase of the study. At the same time, a Cronbach’s alpha of 0.87 on the control group
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Table 5. Fraction of Missing Information (FMI) and Relative Efficiency (RE) for linguistic variables.
Variable

FMI

RE

LM Ia

0.0156

0.9984

LM IIa

0.0094

0.9991

Bostona

0.0229

0.9977

WORDLISTUSED

0.8723

0.9198

WORDLISTTRIALI

0.7855

0.9272

WORDLISTTRIALII

0.8466

0.9220

WORDLISTTRIALIII

0.8550

0.9212

WORDLISTACQUISITION

0.7969

0.9262

WORDLISTDELAYEDRECALL

0.7293

0.9320

WORDLISTRECOGNITION

0.6322

0.9405

a

Component of Linguistic Battery II in Tables 7 & 8.

https://doi.org/10.1371/journal.pone.0229460.t005

emphasizes the observed difference between the MCI-AD and the healthy control groups. The
ten variables identified by Cronbach’s alpha form our independent linguistic battery to be evaluated with machine learning techniques.
Finally, Table 5 shows the Fraction of Missing Information (FMI) and Relative Efficiency
(RE) for the linguistic variables. Although the proportion of missing data for the variables used
in the MI process is approximately 87%, the FMI and RE are better measures that demonstrate
the benefits and efficiency of the MI process [32]. More importantly, each linguistic variable
shows a relative efficiency above 90%, which indicates an effective reduction in bias even when
the proportion of missing data is large.

Evaluation of the linguistic battery with machine learning techniques
To automate the diagnosis of the MCI-AD from healthy control patients [24], we performed
different sets of experiments to verify the hypothesis that an independent linguistic battery
could better diagnose patients with MCI-AD compared to the MMSE, CDR, or a combination
of the MMSE and CDR test battery put together. As such, we build machine learning models
using only the ten variables that loaded in the EFA process and further confirmed reliable by
Cronbach’s alpha.
We verified the importance of covariates in diagnosing patients with MCI-AD. We experimented with and without the four covariates (age, sex, race, and education). We also evaluated
the Linguistic Battery model with and without the CERAD word list.
Each model in our experiment was tuned to the best SVM parameters on a separate 1840
random observations from the total 4840 imputed observations. Consistent with the literature,
our tuning process used 10-fold cross-validation that ensured optimal parameters for each
model [47]. We used the SVM and tune functions in the e1071 R library to perform the tuning
process [38]. The SVM kernel was set to the Radial kernel, the cost parameters range from 10-1
to 102, and the gamma parameter was set to be selected from a default list of 0.5, 1, and 2
parameter values. Using the optimal parameters, the remaining 3000 observations were used
in the final classification for generating the AUC with 10-fold cross-validation. Also, it is
worth mentioning that other variants of the SVM algorithm such as the Recursive Feature
Elimination (RFE) [48], could be used to identify useful features or build classification models
without the EFA technique. However, our goal was to employ an explainable method of analyses parallel to the more complex SVM algorithm. Table 6 shows the identified optimal SVM
parameters for each model.
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Table 6. Identified optimal SVM parameters for each model.
Model

Kernel

Cost

Linguistic Battery I

Radial

10

Gamma
2

Linguistic Battery II

Radial

1

1

MMSE

Radial

0.1

0.5

CDR

Radial

100

1

MMSE & CDR

Radial

100

1

All combined

Radial

1

2

Linguistic Battery I w/ covariates

Radial

10

1

Linguistic Battery II w/ covariates

Radial

1

0.5

MMSE w/ covariates

Radial

1

1

CDR w/ covariates

Radial

0.1

2

MMSE & CDR w/ covariates

Radial

1

2

All combined w/ covariates

Radial

10

2

�

Linguistic Battery I is with CERAD wordlist. Linguistic Battery II excludes CERAD wordlist.

https://doi.org/10.1371/journal.pone.0229460.t006

In the first experiment, we trained an SVM model using all the linguistic variables with the
best Cronbach’s alpha from our correlation analysis to form the independent linguistic battery
I (LMI, LMII, Boston, wordlistused, wordlisttrialI, wordlisttrialII, wordlisttrialIII, wordlistacquisition, wordlistdelayedrecall, and wordlistrecorgnition). Second, we trained an SVM model with
all the linguistic variables except the CERAD word list variables to form an independent linguistic battery II (LMI, LMII, Boston). Third, we trained an SVM model with the MMSE variable. Fourth, we trained an SVM model with the CDR variable. Fifth, we trained an SVM
model with a combination of the MMSE and the CDR variables. Finally, we trained an SVM
model with a combination of the best of linguistic battery I and II, MMSE, and CDR variables.
Table 7 shows the results of the models without the four covariates. More often than not,
the MMSE and the CDR are interpreted independent of the covariates used in this study (i.e.,
age, sex, race, education). Our results show that these covariates could contribute to the effectiveness of the diagnosis of MCI-AD, and thus, should be considered in the context of interpreting the results. Nevertheless, without the covariates, the linguistic battery I showed better
AUC of 0.72 (CI: 0.70-0.73, p<0.0001) and linguistic battery II showed better AUC of 0.88
(CI: 0.86-0.89, p<0.0001) compared to an AUC of 0.59 for the MMSE; 0.55 for CDR; and 0.64
for the combination of MMSE and CDR. These results support the findings in [14, 16, 20],
which found limited evidence that the MMSE could be used to clinically diagnose MCI-AD.
Table 7. Machine learning diagnostic performance of models without covariates using the Area Under the ROC
Curve (AUC)—(No covariates used in the models).
Model

AUC

CI

p-value

Linguistic Battery I

0.72

0.70-0.73

<0.0001

Linguistic Battery II

0.88

0.86-0.89

<0.0001

MMSE

0.59

0.57-0.62

<0.0001

CDR

0.55

0.51-0.58

<0.0001

MMSE & CDR

0.64

0.62-0.66

<0.0001

All combined

0.98

0.97-0.98

<0.0001

�

Linguistic Battery I is with CERAD wordlist. Linguistic Battery II excludes CERAD wordlist.

https://doi.org/10.1371/journal.pone.0229460.t007
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Table 8. Machine learning diagnostic performance of models with covariates using the Area Under the ROC
Curve (AUC)—(Models include covariates).
Model

AUC

CI

p-value

Linguistic Battery I w/ covariates

0.84

0.83-0.86

<0.0001

Linguistic Battery II w/ covariates

0.97

0.96-0.97

<0.0001

MMSE w/ covariates

0.77

0.75-0.78

<0.0001

CDR w/ covariates

0.68

0.66-0.71

<0.0001

MMSE & CDR w/ covariates

0.86

0.85-0.88

<0.0001

All combined w/ covariates

0.99

0.99-1.00

<0.0001

�

Linguistic Battery I is with CERAD wordlist. Linguistic Battery II excludes CERAD wordlist.

https://doi.org/10.1371/journal.pone.0229460.t008

Using the best linguistic battery, we recorded a 29% improvement on the MMSE, 33%
improvement on the CDR, and a 24% improvement on the combination of MMSE and CDR.
Unlike the MMSE and the CDR, we see that the linguistic battery with or without the CERAD
word list is robust to achieve a clinically reliable AUC for diagnosis even when the covariates
are not being considered at all. We believe that the combination of the linguistic battery with
MMSE and CDR improves the AUC of the combined test battery put together by 34%. Overall,
when compared to MMSE and CDR, our results show the linguistic battery alone has the
potential to effectively diagnose patients with MCI-AD without controlling for age, sex, race,
and education.
Table 8 emphasizes the importance of covariates in diagnosing patients with MCI-AD.
The table shows the AUC comparison between the models with covariates. When controlled
for age, sex, race, and education, the linguistic batteries I and II gave robust AUC values of
0.84 (CI: 0.83-0.86, p<0.0001) and 0.97 (CI: 0.96-0.97, p<0.0001), which demonstrates the
effectiveness of the linguistic battery in identifying linguistic biomarkers in patients with
MCI-AD. Compared to using the MMSE alone, the best linguistic battery had a better diagnostic performance by 20%. Similarly, compared to using the CDR alone, the best linguistic
battery showed better diagnostic performance by 28%. Even when both MMSE and CDR are
combined, the best linguistic battery had better performance by 10%. The combination of the
linguistic battery with MMSE and CDR showed showed that the linguistic battery improves
the performance of a combination of MMSE and CDR by 13%. Also, when the covariates are
included, the CDR and MMSE actually do perform much better diagnostically. At the same
time, even though the combination of all measures gives an almost perfect AUC, using the
linguistic battery alone can lead to effective and efficient screening process that avoids the
rigor of having to combine the MMSE and the CDR especially for screening through a large
population [2, 20].
Although the Wechsler LMI, LMII, and Boston variables appeared to be more effective in
the linguistic battery compared to the imputed CERAD word list, benefits of the multiple
imputation technique can be seen in the difference between linguistic battery I and the individual MMSE and CDR test batteries. In Table 7, the linguistic battery I showed a 13% improvement over MMSE, 17% improvement over CDR, and 8% over the combination of MMSE and
CDR. Similarly in Table 8, the linguistic battery showed a 7% improvement over MMSE, 16%
over the CDR, and only lost 2% to a combination of MMSE and CDR, which could easily be
gained by using the linguistic battery II. Notably, we believe the multiple imputation technique
has helped understand the underlying linguistic patterns that could help predict the presence
of MCI-AD without using exhaustive test batteries.
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Furthermore, we constructed heatmaps in the form of hierarchical clustering of the data.
The heatmaps emphasize the sensitivity of the linguistic battery with covariates to capture the
underlying difference between the MCI-AD and the healthy control groups.
Fig 1a and 1b show the underlying patterns of the linguistic battery with covariates by the
group. We observed a unique difference between the underlying patterns of the ten linguistic
variables with Boston, LMI, LMII, wordlistacquisition, and wordlistrecorgnition variables
showing distinct patterns in both heatmaps. Compared to the MCI-AD group, the healthy
control group showed a lighter color gradient across the ten linguistic variables, an indication that the healthy control group performs very well with those variables. The unique
contributions of the covariates were also emphasized in the heatmaps. Compared to the
MCI-AD group, age and education variables showed a lighter color gradient in the healthy
control group. This observation supports the result of the linguistic battery with covariates
in Table 8, which shows improvement over the linguistic battery without covariates in
Table 7.
On the other hand, Fig 2a and 2b show the underlying patterns of the combined MMSE
and CDR variables with the four covariates for MCI-AD and the healthy control group. Across
the MMSE and CDR variables, we observed no distinct difference between the patterns of the
MCI-AD and the healthy control group, an indication that the MMSE and CDR are less sensitive to differentiating patients with MCI-AD from cognitively healthy individuals. More
importantly, we observed that the MMSE and CDR could not be effective without considering
the covariates. A slight difference was observed across the age and education variables, which
yet shows the importance of the covariates in administering neuropsychological tests, hence
supporting the results of the models in Table 8.
Overall, a distinct difference was created by the linguistic battery variables between the
MCI-AD and healthy control individuals. This is an indication that the linguistic battery can
effectively show the difference between patients with MCI-AD and healthy control individuals,
compared to the MMSE, CDR, or a combination of both.

Limitations
One of the limitations of this study is the exploratory nature of the analysis, especially in identifying the underlying linguistic constructs. As a follow-up to the EFA, confirmatory factor
analysis could be performed to validate the assumptions made in the EFA [34, 49].
Another limitation lies in the use of multiple imputation techniques for imputing the missing CERAD wordlist variables for the NACC UDS data. While multiple imputation techniques
have been successful in clinical and epidemiological research [30, 31], there remain ongoing
debates about its implication on the interpretation of findings [29]. We also recognize that
using the third visit only from the NACC UDS dataset might vary the performance from the
other study visits or the average over all the visits.
This study did not use objective measures such as neuroimages due to the absence of such
measures in the datasets used in this study. Future works could include neuroimages in addition to the linguistic battery for clinically diagnosing MCI-AD.
Also, the majority-white dataset is another limitation in this study. There is the possibility
that the results may be associated with the demographics of that population alone. Future
works could consider a dataset with even distribution of the race/ethnicity and other demographic variables to measure their actual impact on the outcome.
Finally, the machine learning algorithm used for building the diagnostic models was tuned
to the optimal parameters on each model [47]. As such, performing similar experiments on a
different dataset would require that the machine learning algorithm is tuned on that dataset to
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Fig 1. Comparison of the underlying patterns of the linguistic battery between the MCI-AD and healthy control
groups. (a) A. MCI-AD group. (b) B. Healthy control group.
https://doi.org/10.1371/journal.pone.0229460.g001
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Fig 2. Comparison of the underlying patterns of combined MMSE and CDR test battery between the MCI-AD
and healthy control groups. (a) A. MCI-AD group. (b) B. Healthy control group.
https://doi.org/10.1371/journal.pone.0229460.g002
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avoid the pitfall of relying in part on the sample’s error variance structure generated by the
machine learning algorithm in this study.

Conclusion
Exploratory factor analysis and a machine learning evaluation of an independent linguistic
battery for diagnosing Mild Cognitive Impairment due to Alzheimer’s disease have been investigated. The linguistic battery combines the language-based CERAD Word List subtests,
Wechsler Logical Memory subtests, and the Boston naming test to distinguish the underlying
linguistic construct of patients with MCI-AD from the healthy control individuals. The linguistic battery consists of ten linguistic variables with distinct underlying linguistic constructs
achieving a Cronbach’s alpha of 0.74 on the MCI-AD group and 0.87 on the healthy control
group. Also, we showed that the linguistic battery could be automated using a robust machine
learning algorithm. The results of the machine learning evaluation using the clinically relevant
AUC measure showed that the best linguistic battery gives a robust AUC of 0.97 when controlled for age, sex, race, and education. At the same time, our results show that the linguistic
battery alone gives a robust diagnostic performance with a clinically reliable AUC of 0.88 without controlling for age, sex, race, and education. Overall, the linguistic battery showed a better
diagnostic performance compared to MMSE, CDR, and a combination of MMSE and CDR.
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